Lucid Diagnostics receives Nasdaq extension until June 16, 2025 to regain bid price compliance

Lucid Diagnostics Inc.

Received Nasdaq letter granting additional 180 days (to June 16, 2025) to meet $1 minimum bid price.
Initial 180-day compliance period ended Dec 18, 2024 without regaining compliance.
To regain compliance, closing bid price must be at least $1 for ten consecutive business days.
Stock continues trading on Nasdaq under LUCD; no immediate delisting effect.
Company intends to consider all available options to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.